AREPANRIX H1N1 3,7µG/AMP. DE 0,25ML DE SUSP. (P.A.)+1AMP. D'EMULSION DE 0,25ML(ADJUVANT) CORRESPONDANT A 3,75µG/0,5ML (OU 3,75µG/DOSE) APRES MELANGE

Active substance (INN): PURIFIED ANTIGEN FRACTIONS OF INACTIVATED SPLIT VIRIONS A / CALIFORNIA / 7/ 2009 (H1N1)v NYMCX - 179A (VACCIN GRIPPAL)

Over the counter
Active substance (INN)
PURIFIED ANTIGEN FRACTIONS OF INACTIVATED SPLIT VIRIONS A / CALIFORNIA / 7/ 2009 (H1N1)v NYMCX - 179A (VACCIN GRIPPAL)
Strength
3,7µG/AMP. DE 0,25ML DE SUSP. (P.A.)+1AMP. D'EMULSION DE 0,25ML(ADJUVANT) CORRESPONDANT A 3,75µG/0,5ML (OU 3,75µG/DOSE) APRES MELANGE
Form
SUSP
Presentation
B/50AMP. DE SUSP. +2X25AMP. D'EMULSION
Manufacturer
GLAXO SMITHKLINE
Country of origin
ROYAUME UNI
Therapeutic class
INFECTIOLOGIE
Pharmacological class
VACCINS
Registration no.
262/ 13 U 453 /09
Read the leafletOfficial record

Where to find this medicine

Availability reported by pharmacies. Pick your wilaya to see nearby pharmacies.

No recent availability reported. Pick a wilaya to search.

Stock statuses are self-reported and may be stale. Always confirm availability by phone before travelling.

A question about this medication?

A doctor can advise on dosage, alternatives and interactions. Book an appointment online.

Find a doctor